Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.53 |
| ▸ | IDO1 | P14902 | 2/20 | 0.47 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.47 |
| ▸ | HTR2A | P28223 | 1/20 | 0.46 |
| ▸ | HTR2C | P28335 | 1/20 | 0.46 |
| ▸ | HTR2B | P41595 | 1/20 | 0.46 |
| ▸ | MIF | P14174 | 1/20 | 0.46 |
| ▸ | ACP3 | P15309 | 1/20 | 0.45 |
| ▸ | DAO | P14920 | 2/20 | 0.45 |
| ▸ | DPP4 | P27487 | 1/20 | 0.44 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 3/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.43 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.43 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1579060 | 0.91 | TAAR1 (0.50) | TAAR1IDO1ALOX5HTR2AHTR2C | |
| SCHEMBL10623823 | 0.85 | CA1 (0.58) | TAAR1IDO1ALOX5HTR2AHTR2C | |
| SCHEMBL9572659 | 0.85 | TAAR1 (0.53) | TAAR1IDO1ALOX5HTR2AHTR2C | |
| SCHEMBL8685464 | 0.84 | IDO1 (0.58) | TAAR1IDO1HTR2AHTR2CHTR2B | |
| SCHEMBL5314366 | 0.84 | IDO1 (0.51) | TAAR1IDO1HTR2AHTR2CHTR2B | |
| SCHEMBL16726983 | 0.84 | IDO1 (0.42) | IDO1DAOKDM4EMEN1KMT2A | |
| SCHEMBL7724359 | 0.81 | FFAR1 (0.49) | TAAR1IDO1ALOX5FFAR4MEN1 | |
| SCHEMBL1170170 | 0.81 | KMT2A (0.51) | TAAR1IDO1MIFDAOMAOB | |
| SCHEMBL858115 | 0.80 | TAAR1 (0.49) | TAAR1IDO1ALOX5DAONR3C1 | |
| SCHEMBL24615983 | 0.79 | TAAR1 (0.61) | TAAR1IDO1ALOX5HTR2AHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150126516-A1 | PIPERIDINE COMPOUND AND ITS USE IN PEST CONTROL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-05-07 | — | — | US | disclosed |
| EP-2845851-A1 | PIPERIDINE COMPOUND AND PEST-CONTROL USE THEREFORE | Sumitomo Chemical Company Limited (JP) | 2015-03-11 | — | — | EP | disclosed |
| CN-104302623-A | Piperidine compound and pest-control use therefore | SUMITOMO CHEMICAL CO | 2015-01-21 | — | — | CN | disclosed |
| EP-0714894-A1 | 3-(1,2,3,6-tetrahydro-(1-alkylenearyl)-4-pyridinyl)- and 3-(1-alkylenearyl)-4-piperidinyl-1h-indoles: new 5-HT1f agonists | ELI LILLY AND COMPANY (US) | 1996-06-05 | — | — | EP | disclosed |
| US-5521197-A | ANALGESICS USING SEROTONIN ANTAGONIST | ELI LILLY AND COMPANY (US) | 1996-05-28 | — | — | US | disclosed |
| EP-0144729-B1 | 11-Substituted 5H,11H-pyrrolo[2,1-c][1,4]benzoxazepines, a process for their preparation and their use in medicaments | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1989-11-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150126516-A1 | PIPERIDINE COMPOUND AND ITS USE IN PEST CONTROL | ZYX, CXXC5, CNBP | TAAR1 110/4885IDO1 1232/4885ALOX5 1911/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.